Mexico Hemorrhoids Treatment Market - Industry Trends and Forecast to 2029
Mexico hemorrhoids treatment market is projected to register a substantial CAGR of 6.9% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.
Market Segmentation:
Mexico Hemorrhoids Treatment Market, By Type (External Hemorrhoids, Internal Hemorrhoids and Prolapsed Hemorrhoids), Treatment (Medication, Surgical Treatment and Non-Surgical Treatment), Route of Administration (Oral, Topical and Others), Dosage Form (Tablets, Capsules, Suppositories, Creams, Ointments, Syrup, Powder and Others), Product Type (Over-the-counter (OTC) and Prescription Drugs), Age Group (Adult, Geriatric, Child), Distribution Channel (Store Based Retail and Online Based Retail), Country (Mexico) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Mexico hemorrhoids treatment market are:
. Increasing prevalence and diagnosis
. Growing adoption of sedentary lifestyle & poor fiber intake
Market Players:
The key market players for Mexico hemorrhoids treatment market are listed below:
. Teva Pharmaceutical industries Ltd.
. GENOMMA LAB
. Glaxosmith Kline
. Abbott
. Abbvie Inc.
. Perrigo Company Plc
. Sanofi
. Bayer AG
. Chinoin
. Medtronic plc
. Procter & Gamble
. Pfizer Inc.
. Sandoz AG (A division of Novartis AG)
. Fresenius Kabi Mexico, S.A. de C.V. (A Subsidiary of Fresenius Kabi)
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook